ENTITY
Grifols

Grifols (GRFS US)

19
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x